An open-label clinical trial of agalsidase alfa enzyme replacement therapy in children with Fabry disease who are naïve to enzyme replacement therapy

Özlem Göker-Alpan, Nicola Longo, Timothy J. McDonald, Suma P. Shankar, Raphael Schiffmann, Peter Chang, Yinghua Shen, Arian PanoDrug 2016 · DOI

Abstract

https://ClinicalTrials.gov identifier NCT01363492.
BibTeX
@inproceedings{gokeralpan2016open,
  author = {Özlem Göker-Alpan and Nicola Longo and Timothy J. McDonald and Suma P. Shankar and Raphael Schiffmann and Peter Chang and Yinghua Shen and Arian Pano},
  title = {{An open-label clinical trial of agalsidase alfa enzyme replacement therapy in children with Fabry disease who are na\ïve to enzyme replacement therapy}},
  booktitle = {Drug},
  year = {2016},
  doi = {10.2147/dddt.s102761},
}

Loading related content...

Figure